Graves’ disease is an autoimmune disorder affecting
approximately 0.3% of people living in the United States and 0.5% of
the world population.
Pharmaceutical companies view branded generics as a valuable commodity, but will economic pressures push consumers toward these products' lower-cost, unbranded counterparts?
The agency is stepping up its efforts to ensure that overseas generic as well as brand name drug manufacturers are maintaining the high standards necessary to produce safe, quality products.
Assessment of cost concerns is an important aspect of caring for a patient during a medication review.
Beginning in 2014, millions of additional patients will have access to
health care as a result of health care reform legislation, making
reimbursements to pharmacists an increasingly important issue.